CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to JNJ

topiramate

Phase 3
Johnson & Johnson (JNJ)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Essential Tremor

View Full Landscape
Drug Information

Target Indication

Essential Tremor

Clinical Trial

NCT00236496

Last updated: 12/4/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Aug 21, 2040(13y 11m)

Patents Listed

20

Exclusivity

CGTPC

Application

NDA 201635
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.